Truist Securities Maintains Hold on Cross Country Healthcare, Lowers Price Target to $15

Benzinga · 10/21 15:02
Truist Securities analyst Tobey Sommer maintains Cross Country Healthcare (NASDAQ:CCRN) with a Hold and lowers the price target from $17 to $15.